| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Abpro (ABP) | UBS Investment Bank/ Wells Fargo Securities | $69.00 | n.a. | |||
| BayCom (BCML) | FIG Partners/ D.A. Davidson | $57.50 | n.a. | |||
| Carbon Black (CBLK) | Morgan Stanley/ J.P. Morgan | $100.00 | n.a. | |||
| Evelo Biosciences (EVLO) | Morgan Stanley/ Cowen/ BMO Capital Markets | $100.00 | n.a. | |||
| HUYA (HUYA) | Credit Suisse/ Goldman Sachs (Asia)/ UBS Investment Bank | $200.00 | n.a. | |||
| Origin Bancorp (OBNK) | Stephens/ Raymond James | $90.00 | n.a. | |||
| Trinity Merger (TMCXU) (u) | B. Riley FBR | 30.00 | $10.00 | $10.00 | $300.00 | n.a. |
| n.a. (not available) | ||||||
| u (unit offering) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Ceridian HCM Holding (CDAY) | Goldman Sachs/ J.P. Morgan/ Credit Suisse/ Deutsche Bank Securities | 21.00 | $19.00 | $21.00 | $420.00 | S/O |
| FirstCaribbean International Bank Ltd (FCI) | Barclays/ UBS Investment Bank/ CIBC Capital Markets | 9.60 | $22.00 | $25.00 | $225.60 | a |
| Level One Bancorp (LEVL) | Raymond James/ Keefe, Bruyette & Woods (A Stifel Company) | 1.00 | $27.00 | $29.00 | $28.00 | S/O |
| Mereo BioPharma Group plc (MREO) | Cowen/ BMO Capital Markets/ RBC Capital Markets | 2.84 | $17.62 | $17.62 | $50.01 | b |
| MorphoSys AG (MOR) | Goldman Sachs/ J.P. Morgan/ Leerink Partners | 8.30 | $24.12 | $24.12 | $200.20 | c |
| Pivotal Software PVTL) | Morgan Stanley/ Goldman Sachs/ Citigroup | 37.00 | $14.00 | $16.00 | s | S/O |
| Surface Oncology (SURF) | Goldman Sachs/ Cowen/ Evercore ISI | 6.00 | $13.00 | $15.00 | $84.00 | S/O |
| Zuora (ZUO) | Goldman Sachs/ Morgan Stanley/ Allen & Company/ Jefferies | 10.00 | $11.00 | $13.00 | $120.00 | S/O |
| S/O (Subscribers Only) | ||||||
| N/C (a) = No Call – Stock is traded on the Barbados Stock Exchange and the Trinidad and Tobago Stock Exchange | ||||||
| N/C (b) = No Call – Stock is traded on the AIM market of the London Stock Exchange since 2016 | ||||||
| N/C (c) = No Call – Stock has been listed on the Frankfurt Stock Exchange since 2013 | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of April 9, 2018 | Manager(s) | Offered | Raised | Price | 4/13/18 | Change |
| Zuora (ZUO) | Goldman Sachs/ Morgan Stanley/ Allen & Company/ Jefferies | 11.00 | $154.00 | $14.00 | $20.60 | 47.14% |
| Pure Acquisition ( PACQU) (u) | Oppenheimer/ EarlyBirdCapital | 36.00 | $360.00 | $10.00 | $10.12 | 1.20% |
| u (unit offering) | ||||||
